🇺🇸 FDA
Patent

US 10408834

Mutated parvovirus structural proteins as vaccines

granted A61KA61K2039/5256A61K39/00

Quick answer

US patent 10408834 (Mutated parvovirus structural proteins as vaccines) held by Ludwig-Maximilians-Universitat Munchen expires Mon Sep 05 2039 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Ludwig-Maximilians-Universitat Munchen
Grant date
Tue Sep 10 2019 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Sep 05 2039 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
24
CPC classes
A61K, A61K2039/5256, A61K39/00, A61P, A61P1/04